Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013 (2013), Article ID 496031, 7 pages
http://dx.doi.org/10.1155/2013/496031
Clinical Study

Association between Preoperative Plasma sRAGE Levels and Recovery from Cardiac Surgery

1Unit of Critical Care, Respiratory Science, National Heart and Lung Institute Division (NHLI), Faculty of Medicine, Imperial College London, Dovehouse Street, London SW3 6LY, UK
2NIHR Respiratory Disease Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, London SW3 6NP, UK

Received 26 April 2013; Accepted 1 August 2013

Academic Editor: Elzbieta Kolaczkowska

Copyright © 2013 Benedict C. Creagh-Brown et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. Creagh-Brown, G. J. Quinlan, T. W. Evans, and A. Burke-Gaffney, “The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?” Intensive Care Medicine, vol. 36, no. 10, pp. 1644–1656, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. T. Buckley and C. Ehrhardt, “The receptor for advanced glycation end products (RAGE) and the lung,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 917108, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Gebhardt, J. Németh, P. Angel, and J. Hess, “S100A8 and S100A9 in inflammation and cancer,” Biochemical Pharmacology, vol. 72, no. 11, pp. 1622–1631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Fontaine, A. Pachot, A. Larue et al., “Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock,” Critical Care Medicine, vol. 39, no. 12, pp. 2684–2690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Payen, A. Lukaszewicz, I. Belikova et al., “Gene profiling in human blood leucocytes during recovery from septic shock,” Intensive Care Medicine, vol. 34, no. 8, pp. 1371–1376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. D. van Zoelen, T. Vogl, D. Foell et al., “Expression and role of myeloid-related protein-14 in clinical and experimental sepsis,” The American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 11, pp. 1098–1106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. de Torre, S. Ying, P. J. Munson, G. U. Meduri, and A. F. Suffredini, “Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage,” Proteomics, vol. 6, no. 13, pp. 3949–3957, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bierhaus, S. Schiekofer, M. Schwaninger et al., “Diabetes-associated sustained activation of the transcription factor nuclear factor-κB,” Diabetes, vol. 50, no. 12, pp. 2792–2808, 2001. View at Google Scholar · View at Scopus
  9. H. Bruunsgaard, M. Pedersen, and B. K. Pedersen, “Aging and proinflammatory cytokines,” Current Opinion in Hematology, vol. 8, no. 3, pp. 131–136, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Yamagishi and T. Matsui, “Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker,” Frontiers in Bioscience, vol. 2, pp. 1184–1195, 2010. View at Google Scholar · View at Scopus
  11. N. Vazzana, F. Santilli, C. Cuccurullo, and G. Davì, “Soluble forms of RAGE in internal medicine,” Internal and Emergency Medicine, vol. 4, no. 5, pp. 389–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Christaki, N. Lazaridis, and S. M. Opal, “Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?” Current Opinion in Infectious Diseases, vol. 25, no. 3, pp. 304–311, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. W. A. Guo, P. R. Knight, and K. Raghavendran, “The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome,” Intensive Care Medicine, vol. 38, no. 10, pp. 1588–1598, 2012. View at Publisher · View at Google Scholar
  14. C. S. Calfee, L. B. Ware, M. D. Eisner et al., “Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury,” Thorax, vol. 63, no. 12, pp. 1083–1089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Jabaudon, E. Futier, L. Roszyk et al., “Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients,” Critical Care Medicine, vol. 39, no. 3, pp. 480–488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kikkawa, N. Sato, M. Kojika et al., “Significance of measuring S100A12 and sRAGE in the serum of sepsis patients with postoperative acute lung injury,” Digestive Surgery, vol. 27, no. 4, pp. 307–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Nakamura, E. Sato, N. Fujiwara, Y. Kawagoe, S. Maeda, and S. Yamagishi, “Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome,” Clinical Biochemistry, vol. 44, no. 8-9, pp. 601–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Lindström, E. Tukiainen, L. Kylänpää et al., “Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis,” Pancreas, vol. 38, no. 8, pp. e215–e220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Bopp, S. Hofer, J. Weitz et al., “sRAGE is elevated in septic patients and associated with patients outcome,” Journal of Surgical Research, vol. 147, no. 1, pp. 79–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Narvaez-Rivera, A. Rendon, M. C. Salinas-Carmona, and A. G. Rosas-Taraco, “Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis,” BMC Infectious Diseases, vol. 12, article 15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Cohen, M. Carles, K. Brohi et al., “Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans,” Journal of Trauma, vol. 68, no. 6, pp. 1273–1278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Liu, Q. Chen, S. Shi et al., “Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children,” Critical Care, vol. 16, no. 3, article R91, 2012. View at Google Scholar
  23. P. Agostoni, C. Banfi, M. Brioschi et al., “Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study,” European Respiratory Journal, vol. 37, no. 4, pp. 841–847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Erdil, V. Nisanoglu, M. Kaynak et al., “On-pump coronary artery bypass surgery in high-risk patients aged over 65 years (EuroSCORE 6 or more): impact on early outcomes,” Journal of International Medical Research, vol. 37, no. 3, pp. 884–891, 2009. View at Google Scholar · View at Scopus
  25. R. C. Landis, J. E. Arrowsmith, R. A. Baker et al., “Consensus statement: defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass,” The Heart Surgery Forum, vol. 11, no. 5, pp. E316–E322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Eddleston, D. Goldhill, and J. Morris, Levels of Critical Care for Adult Patients, Intensive Care Society Standards, 2009, http://www.rcn.org.uk/__data/assets/pdf_file/0005/435587/ICS_Levels_of_Critical_Care_for_Adult_Patients_2009.pdf.
  27. I. Simera, D. Moher, J. Hoey, K. F. Schulz, and D. G. Altman, “A catalogue of reporting guidelines for health research,” European Journal of Clinical Investigation, vol. 40, no. 1, pp. 35–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Bridgewater, B. Keogh, R. Kinsman, and P. Walton, Sixth National Cardiac Database Report, Cardiac Surgey 2009, 2009, http://www.e-dendrite.com/files/13/file/Pages%20from%20NACSD%202008.pdf.
  29. J. M. Dieleman, A. P. Nierich, P. M. Rosseel et al., “Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial,” The Journal of the American Medical Association, vol. 308, no. 17, pp. 1761–1767, 2012. View at Publisher · View at Google Scholar
  30. J. C. Simard, D. Girard, and P. A. Tessier, “Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism,” Journal of Leukocyte Biology, vol. 87, no. 5, pp. 905–914, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Goyette and C. L. Geczy, “Inflammation-associated S100 proteins: new mechanisms that regulate function,” Amino Acids, vol. 41, no. 4, pp. 821–842, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Pavelkova, L. Kubala, M. Ciz et al., “Blood phagocyte activation during open heart surgery with cardiopulmonary bypass,” Physiological Research, vol. 55, no. 2, pp. 165–173, 2006. View at Google Scholar
  33. J. H. Levy and K. A. Tanaka, “Inflammatory response to cardiopulmonary bypass,” Annals of Thoracic Surgery, vol. 75, no. 2, pp. S715–S720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Suda, Y. Kitagawa, S. Ozawa et al., “Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery?” Diseases of the Esophagus, vol. 19, no. 1, pp. 5–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Atoui, F. Ma, Y. Langlois, and J. F. Morin, “Risk factors for prolonged stay in the intensive care unit and on the ward after cardiac surgery,” Journal of Cardiac Surgery, vol. 23, no. 2, pp. 99–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. R. G. A. Ettema, L. M. Peelen, M. J. Schuurmans, A. P. Nierich, C. J. Kalkman, and K. G. M. Moons, “Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study,” Circulation, vol. 122, no. 7, pp. 682–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. O. V. Hein, J. Birnbaum, K. Wernecke, M. England, W. Konertz, and C. Spies, “Prolonged intensive care unit stay in cardiac surgery: risk factors and long-term-survival,” Annals of Thoracic Surgery, vol. 81, no. 3, pp. 880–885, 2006. View at Publisher · View at Google Scholar · View at Scopus